New Form 8-K - FIBROGEN INC Filed: 2025-09-05 AccNo: 0000921299-25-000007 Size: 525 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits
Elsbernd Brian 🟡 adjusted position in 50.0K shares (2 derivative) of CATALYST PHARMACEUTICALS, INC. (CPRX) at $20.08 ($1.2M) Transaction Date: Sep 03, 2025 | Filing ID: 000318